$21.490
-0.011 (-0.05%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NAMS por análisis de gráficos similares
Alphio's NAMS stock price prediction model matches the current NewAmsterdam Pharma Company NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $21.28 (-0.96%). The 1-week path is $21.51 (+0.10%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma is not a good buy right now due to significant financial losses and negative market sentiment. The stock is currently priced at $19.83, down 43.66% year-to-date, and has an RSI of 25.93, indicating it is oversold. The company reported a net loss of $64.1 million in Q2 2026, a substantial increase from previous losses, which raises concerns about its financial health and market competitiveness. Additionally, insider selling has increased by 113.69%, suggesting a lack of confidence from those closest to the company. The main risk is the forward P/E ratio of 119.05, indicating high valuation expectations that may not be met given the current financial performance.
NAMS cerró en $21.49 el Wednesday, tras bajar -0.05%
NewAmsterdam Pharma Company NV (NAMS) last closed at $21.49, losing -0.05%. These facts feed the 1-day and 1-week NAMS price prediction above.
Factores de la previsión
Los factores de la previsión de NewAmsterdam Pharma Company NV (NAMS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NAMS, ordenadas por similitud.
Análisis de estacionalidad de NAMS
Historically the probability of a positive October return for NAMS is 75.41%. November offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NAMS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $24.81 | $32.88 | $41.42 | +52.99% |
| Nov 2026 | $33.96 | $41.82 | $49.82 | +94.60% |
| Dec 2026 | $33.82 | $41.16 | $42.47 | +91.52% |
En 2026, se proyecta que NewAmsterdam Pharma Company NV (NAMS) oscile entre $24.81 y $49.82.
Previsión mensual de NewAmsterdam Pharma Company NV para 2026
En Oct de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $32.88, con un mínimo de $24.81 y un máximo de $41.42.
En Nov de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $41.82, con un mínimo de $33.96 y un máximo de $49.82.
En Dec de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $41.16, con un mínimo de $33.82 y un máximo de $42.47.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.